Literature DB >> 29246814

Neuroborreliosis and acute encephalopathy: The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis.

Matthias Karrasch1, Volker Fingerle2, Katharina Boden3, Andreas Darr4, Michael Baier5, Eberhard Straube5, Igor Nenadic6.   

Abstract

We report the case of an 80-year-old patient with acute onset confusion initially suspected to reflect delirium in incipient Alzheimer's disease. Cerebrospinal fluid tests revealed an unusually severe form of neuroborreliosis, which resolved following antibiotic treatment. This was mirrored in the measurement of CXCL13, which is suggested as a complementary biomarker. Clinical implications for screening, differential diagnosis and treatment are discussed.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Borrelia burgdorferi; CXCL13; Cerebrospinal fluid; Neuroborreliosis

Mesh:

Substances:

Year:  2017        PMID: 29246814     DOI: 10.1016/j.ttbdis.2017.12.008

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  3 in total

1.  The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.

Authors:  Fredrikke Christie Knudtzen; Anna Christine Nilsson; Joppe W Hovius; Sigurdur Skarphedinsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-03-14       Impact factor: 3.267

2.  Lyme Meningoencephalitis Masquerading as Normal Pressure Hydrocephalus.

Authors:  Aakash Desai; Gaurav Manek; Anand M Krishnan; Corina Iorgoveanu; Ahmed Zaghloul
Journal:  Cureus       Date:  2018-04-03

Review 3.  Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.

Authors:  Monika Gudowska-Sawczuk; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.